Clinical Trials Directory

Trials / Completed

CompletedNCT01931527

Effect of Reducing Uric Acid on Insulin Sensitivity and Oxidative Status

Effect of Plasma Uric Acid on Insulin Sensitivity, Endothelial Function and Inflammation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to learn more about what is the effect of uric acid on oxidative stress and on the way the body metabolizes sugar in obese people. Understanding this may lead to better diseases such as diabetes.

Detailed description

It has been hypothesized that oxidative stress is involved in the pathogenesis of insulin resistance associated with obesity. Circulating uric acid (UA) is the body's major endogenous plasma antioxidant. Therefore, the investigators evaluated whether alterations in serum UA concentration affect: 1) systemic and skeletal muscle oxidative stress, 2) total antioxidant capacity, and 4) skeletal muscle insulin sensitivity during a hyperinsulinemic-euglycemic clamp.

Conditions

Interventions

TypeNameDescription
DRUGRasburicaseone single infusion of rasburicase (0.19 mg/kg FFM) infused over 30 min

Timeline

Start date
2006-07-01
Primary completion
2008-06-01
Completion
2012-11-01
First posted
2013-08-29
Last updated
2018-08-14
Results posted
2015-05-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01931527. Inclusion in this directory is not an endorsement.